Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 12.80% and Operating profit at 0.40% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.10
Flat results in Sep 25
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 11 Cr (Micro Cap)
29.00
29
0.00%
-0.01
3.17%
0.93
Total Returns (Price + Dividend) 
Indo Euro Indch. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
How has been the historical performance of Indo Euro Indch.?
Answer: The historical performance of Indo Euro Indch. shows a fluctuating trend in net sales and profitability over the years. Breakdown: Indo Euro Indch. reported net sales of 13.89 Cr in March 2025, an increase from 10.82 Cr in March 2024 and 10.08 Cr in March 2023, but a decline from 22.64 Cr in March 2022. The total operating income followed a similar trend, reaching 13.89 Cr in March 2025. However, the total expenditure increased to 14.03 Cr in March 2025 from 11.38 Cr in March 2024, leading to an operating profit (PBDIT) of -0.14 Cr in March 2025, which is an improvement from -0.56 Cr in March 2024 but down from 0.57 Cr in March 2022. Profit before tax rose to 0.40 Cr in March 2025 from 0.12 Cr in March 2024, while profit after tax also improved to 0.36 Cr in March 2025 compared to 0.04 Cr in March 2024. The company's total assets increased to 19.49 Cr in March 2025 from 16.32 Cr in March 2024, with...
Read MoreHow has been the historical performance of Indo Euro Indch.?
Answer: The historical performance of Indo Euro Indch. shows a fluctuating trend in net sales and profitability over the years. Breakdown: Indo Euro Indch. reported net sales of 13.89 Cr in March 2025, an increase from 10.82 Cr in March 2024 and 10.08 Cr in March 2023, but a decline from 22.64 Cr in March 2022. The total operating income followed a similar pattern, reaching 13.89 Cr in March 2025. However, the total expenditure increased to 14.03 Cr in March 2025 from 11.38 Cr in March 2024, leading to an operating profit (PBDIT) of -0.14 Cr in March 2025, which was an improvement from -0.56 Cr in March 2024. Profit before tax rose to 0.40 Cr in March 2025, compared to 0.12 Cr in March 2024, while profit after tax also increased to 0.36 Cr from 0.04 Cr. The company’s total assets grew to 19.49 Cr in March 2025 from 16.32 Cr in March 2024, with total liabilities also increasing to 19.49 Cr. The book value p...
Read MoreWhy is Indo Euro Indch. falling/rising?
As of 07-Nov, Indo Euro Indchem Ltd is experiencing a decline in its stock price, currently at 11.83, which reflects a decrease of 0.05 or 0.42%. The stock has been on a downward trend, having lost 6.11% over the last three days, and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance relative to the market, the stock has shown a significant decline of 26.93% year-to-date and 29.79% over the past year, contrasting sharply with the Sensex, which has gained 6.50% and 4.62% respectively during the same periods. Although there has been a notable increase in investor participation, with delivery volume rising by 122.78% against the 5-day average, the overall sentiment appears negative. Broader Market Context: In the short term, Indo Euro Indchem Ltd's performance has been considerably worse than the benchmark Sensex, which has only declined by 0.86% over the...
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSENewspaper Advertisement
Announcement under Regulation 30 (LODR)-Resignation of Director
13-Nov-2025 | Source : BSEAnnouncement of Resignation of Independent Director
Announcement under Regulation 30 (LODR)-Change in Directorate
13-Nov-2025 | Source : BSEAnnouncement of Appointment of Resignation of Independent Director in the Board Meeting 13th November 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Vardhman Chhaganlal Shah (26.57%)
Abhay Shrawan Nikam (1.91%)
40.12%
Quarterly Results Snapshot (Standalone) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is 208.79% vs -83.12% in Sep 2024
YoY Growth in quarter ended Sep 2025 is 800.00% vs -98.86% in Sep 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -25.51% vs 143.33% in Sep 2024
Growth in half year ended Sep 2025 is 4.35% vs 2,200.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is 195.31% vs -53.29% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 2,100.00% vs -97.40% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 28.37% vs 7.34% in Mar 2024
YoY Growth in year ended Mar 2025 is 800.00% vs -81.82% in Mar 2024






